Today: 4 March 2026
Subscribe
Browse Category

Stock Market 29 October 2025

Constellation Software (CSU.TO) Stock Plunges on Founder’s Exit – Analysts See 58% Upside

Constellation Software (CSU.TO) Stock Plunges on Founder’s Exit – Analysts See 58% Upside

Constellation Software shares closed at C$3,453.88 on Oct. 29, down 8% for the day and nearly 30% below their 52-week high. Founder Mark Leonard resigned as president in late September for health reasons; Mark Miller was promoted. Q2 revenue rose 15% to US$2.84 billion, but GAAP net income dropped 68% on one-time items. Analysts remain bullish, with an average target of C$5,450.
29 October 2025
·
ServiceNow (NOW) Stock Soars on AI-Driven Earnings and 5-for-1 Stock Split

ServiceNow (NOW) Stock Soars on AI-Driven Earnings and 5-for-1 Stock Split

ServiceNow shares closed at $911.70 on Oct. 29, down 2.8%, but jumped about 4% in after-hours trading after strong Q3 results and a five-for-one stock split announcement. Subscription revenue rose 21.5% to $3.30 billion, beating forecasts. The company raised its full-year sales outlook. Analysts maintain a “Strong Buy” rating, with average targets near $1,117.
29 October 2025
···
Chipotle Stock Tumbles on Third Forecast Cut — Can the Burrito Chain Bounce Back?

Chipotle Stock Tumbles on Third Forecast Cut — Can the Burrito Chain Bounce Back?

Chipotle shares closed at $40.40 on Oct. 29, down 31% from early 2025. The company reported Q3 adjusted EPS of $0.29 on $3.00 billion revenue, missing sales estimates and posting just 0.3% same-store growth. Management cut its 2025 outlook for the third time, now expecting same-store sales to decline. The stock fell 1–2% after hours following the update.
29 October 2025
··
MercadoLibre Stock Slides Amid Fintech Boom – Analysts Predict Big 2025 Comeback

MercadoLibre Stock Dips After Q3 Earnings Miss – Can Brazil Deal Ignite a Rally?

MercadoLibre closed at $2,290 on Oct. 28, up 20% year-to-date, with a market cap near $116 billion. Q3 revenue rose 39% to $7.41 billion, beating estimates, but net income of $421 million missed forecasts. The company announced a deal to sell Casas Bahia appliances and entered Brazil’s online pharmacy market. Shares dipped 1.6% after earnings; most analysts remain bullish with a $2,800 target.
29 October 2025
···
Symbotic Stock Skyrockets on AI Robotics Boom – Is SYM’s 200% Rally Just the Start?

Symbotic Stock Skyrockets on AI Robotics Boom – Is SYM’s 200% Rally Just the Start?

Symbotic Inc. shares surged 4% to around $71–$72 on October 29, nearing their record high. The stock is up over 170% in 2025, driven by demand for AI and robotics, but analysts remain divided, with a consensus “Hold” and price targets far below current levels. Fiscal Q3 revenue rose 26% to $592 million, beating forecasts, while the company reported a $22.4 billion backlog. Symbotic acquired Walmart’s robotics arm and launched new automation tech this year.
29 October 2025
···
ProPetro (PUMP) Soars on Data Center Power Deal and Q3 Earnings Beat – What’s Driving the Rally?

ProPetro (PUMP) Soars on Data Center Power Deal and Q3 Earnings Beat – What’s Driving the Rally?

ProPetro shares surged nearly 14% after its PROPWR unit secured a long-term contract to supply 60 megawatts to a major data center. Q3 revenue reached about $294 million, down 18.6% year-over-year but beating estimates by 14%. The company narrowed its quarterly loss to $2 million and reported $25 million in free cash flow from fracking. PROPWR’s total contracted capacity now exceeds 150 MW.
29 October 2025
····
Purple Biotech (PPBT) Stock Skyrockets ~100% on Breakthrough News – What’s Driving the Surge?

Purple Biotech (PPBT) Stock Skyrockets ~100% on Breakthrough News – What’s Driving the Surge?

Purple Biotech (NASDAQ: PPBT) shares surged 82% to $1.06 on October 29 after announcing a manufacturing breakthrough for its tri-specific antibody IM1240. The company, recently out of Nasdaq compliance for trading under $1, plans a 2026 IND filing. Analysts remain bullish despite ongoing losses and volatility. Purple raised $6 million in September, with a shareholder meeting set for December 15.
29 October 2025
·
Ernexa Therapeutics (ERNA) Skyrockets on Cancer Therapy Deal – Will Rally Last?

Ernexa Therapeutics (ERNA) Skyrockets on Cancer Therapy Deal – Will Rally Last?

Ernexa Therapeutics shares jumped nearly 50% to $1.80 intraday on October 29, 2025, after announcing a manufacturing partnership with Cellipont Bioservices to advance its ovarian cancer cell therapy, ERNA-101, toward clinical trials. Trading volume surged. Despite the rally, ERNA stock remains down about 58% in 2025 and 89% year-on-year after previous setbacks and a reverse stock split.
29 October 2025
··
Meta’s Q3 Showdown: Can AI Spend and Ad Growth Drive Another Rally?

Meta’s Stock Plunges 6% After Shocking Q3 Earnings: AI Costs and $15B Tax Bombshell

Meta posted Q3 2025 revenue of $51.24 billion, up 26% and above forecasts, driven by strong ad sales and 3.54 billion daily users. GAAP EPS fell to $1.05 after a $15.93 billion tax charge, far below analyst estimates, but adjusted EPS was $7.25. Shares closed flat at $752 before dropping 6% after hours. Meta raised 2025 capex guidance to $70–72 billion for AI data centers.
29 October 2025
···
Mastercard Stock Climbs on New Tech, Stablecoin Push and Partnerships

Mastercard’s $2B Crypto Blitz: ZeroHash Acquisition & Stablecoin Push Ignite Stock Hype

Mastercard is in late-stage talks to acquire crypto infrastructure firm ZeroHash for $1.5–2.0 billion, according to Reuters and Crypto Briefing. ZeroHash, valued at $1 billion after a recent $104 million raise, provides fiat-to-crypto rails for banks and fintechs. Mastercard shares traded near $570 on Oct. 22, close to their 52-week high, with analysts broadly bullish.
29 October 2025
····
BigBear.ai Stock’s 300% Surge Sparks Palantir Comparisons in Defense AI Frenzy

BigBear.ai’s 300% Defense AI Stock Rally: Palantir Comparisons & Wild Swings – Can BBAI Keep Soaring?

BigBear.ai Holdings (NYSE: BBAI) shares jumped nearly 300% in 2025, peaking at $9.39 in October before retreating to $6.78. The surge followed new U.S. defense AI contracts and airport facial recognition rollouts. Q2 revenue fell 18% to $32.5 million, with a $228.6 million net loss. Analysts remain divided, with most ratings at “Hold” and price targets below current levels.
29 October 2025
···
Varonis Stock Plummets 45% After Weak Q3 Earnings – Analysts React to Shock Guidance Cut

Varonis Stock Plummets 45% After Weak Q3 Earnings – Analysts React to Shock Guidance Cut

Varonis Systems shares plunged about 45% on October 29, closing near $34 after Q3 revenue missed estimates and the company slashed its outlook. Management cited a late-quarter slowdown and plans to phase out on-premises products by 2026. The board approved a $150 million buyback and a 5% workforce cut. Analysts cut price targets, with at least one downgrade, as the stock’s steep drop erased much of its 2025 gains.
29 October 2025
··
Oracle’s ‘Truly Awesome’ AI Cloud Quarter Sends Stock Soaring 36%, Making Ellison World’s Richest

Oracle Stock Soars on AI Cloud Mega-Deals, Edges Toward Trillion-Dollar Dream

Oracle shares traded near $278 on Oct. 29, 2025, up about 70–75% year-to-date after record highs and major AI-driven cloud deals. The company signed a $300 billion contract with OpenAI and a $20 billion pact with Meta, pushing its cloud backlog to $455 billion. Fiscal Q1 2026 revenue rose 12% to $14.93 billion. Analysts remain bullish, but some warn of risks tied to large AI customers.
29 October 2025
···
New Fortress Energy Seeks U.K. Lifeline to Dodge Bankruptcy – Shares Crash as $9 B Debt Weighs

New Fortress Energy Seeks U.K. Lifeline to Dodge Bankruptcy – Shares Crash as $9 B Debt Weighs

New Fortress Energy is weighing a U.K. “scheme of arrangement” to restructure about $9 billion in debt, aiming to avoid U.S. Chapter 11 bankruptcy. Shares plunged 8% Wednesday, extending a 90% year-to-date drop, as investors reacted to mounting bankruptcy fears. Moody’s downgraded NFE to Caa1 in March, citing weak liquidity and high leverage. Bondholders have organized to negotiate as the company seeks a global debt deal.
29 October 2025
···
Plug Power (PLUG) Stock’s 170% Hydrogen Rally Hits a Wall – Can PLUG Bounce Back?

Plug Power (PLUG) Stock’s 170% Hydrogen Rally Hits a Wall – Can PLUG Bounce Back?

Plug Power (PLUG) traded near $2.85 midday Oct. 29, 2025, after falling 6% to $2.79 earlier. Shares surged 170% from late summer to an October high of $4.58, then dropped back to the high-$2 range. Plug recently raised $370 million in cash and secured a $1.66 billion DOE loan guarantee. CEO Andy Marsh will step down in 2026, with José Luis Crespo set to take over.
29 October 2025
··
Alphabet Stock Soars Ahead of Q3 Earnings: AI Frenzy Fuels $3 Trillion Dreams

Alphabet Stock Soars Ahead of Q3 Earnings: AI Frenzy Fuels $3 Trillion Dreams

Alphabet Inc. stock hit record highs in late October 2025, closing near $265 and approaching a $3 trillion valuation. The company reports Q3 earnings on October 29, with analysts expecting revenue near $100 billion and profit around $2.30 per share. Google’s ad business rebounded sharply, while cloud revenue jumped 32% year-over-year. In September, a U.S. judge rejected calls to break up Google in a key antitrust case.
29 October 2025
····
Fed Cuts Rates Amid Data “Fog” – Stocks Hit Record Highs as More Easing Likely

Fed Cuts Rates Amid Data “Fog” – Stocks Hit Record Highs as More Easing Likely

The Federal Reserve cut its key interest rate by 0.25% on October 29, setting the target range at 3.75–4.00%, its second reduction this year. The move came despite missing economic data due to a prolonged government shutdown. U.S. stocks hit record highs ahead of the decision. Fed Chair Jerome Powell warned of a softer labor market and rising risks to employment.
29 October 2025
··
UnitedHealth Stock Rallies After Bold Strategy Overhaul – Is 2026 a Turning Point?

UnitedHealth Stock Rallies After Bold Strategy Overhaul – Is 2026 a Turning Point?

UnitedHealth reported Q3 revenue of $113.2 billion, up 12% year-over-year, and raised its 2025 adjusted EPS outlook to at least $16.25, above consensus. Shares traded near $360 on Oct. 29, about 30% below April’s peak. The company will shift more doctors to employment and exit lower-profit markets. Q3 medical-loss ratio was about 89.9%, and UnitedHealth remains under federal Medicare Advantage scrutiny.
29 October 2025
·
1 … 1,229 1,230 1,231 1,232 1,233 … 1,331
Go toTop